EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001201:Ascites / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D001424:Bacterial Infections / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000627:therapeutic use; D006530:Hepatorenal Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D007010:Hyponatremia / Q000209:etiology / Q000628:therapy; D008103:Liver Cirrhosis / Q000150:complications* / Q000628:therapy*; D016031:Liver Transplantation; D019152:Paracentesis; D010538:Peritonitis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D019168:Portasystemic Shunt, Transjugular Intrahepatic; D011379:Prognosis
D000900:Anti-Bacterial Agents; D004232:Diuretics